Fred Hutch spinout Affini-T Therapeutics lands $175M for cell therapies to treat solid tumors by Charlotte Schubert on March 22, 2022March 31, 2022 at 8:41 pm New funding: Affini-T Therapeutics, a cell therapy company spun out of Fred Hutchinson Cancer Research Center that aims to treat solid tumors, raised $175 million in initial financing. Fred Hutch… Read More